PubRank

A Mire-Sluis

Author PubWeight™ 9.99‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Taking immunogenicity assessment of therapeutic proteins to the next level. Biologicals 2011 1.12
2 Recombinant human interleukin-4 inhibits growth of some human lung tumor cell lines in vitro and in vivo. Blood 1993 0.91
3 Establishment of new and replacement World Health Organization International Biological Standards for human interferon alpha and omega. J Immunol Methods 2001 0.87
4 Assays for measuring soluble cellular adhesion molecules and soluble cytokine receptors. J Immunol Methods 1996 0.84
5 Platelet c-mpl expression is dysregulated in patients with essential thrombocythaemia but this is not of diagnostic value. Br J Haematol 1999 0.83
6 The developing role of cytokines for imaging inflammation and infection. Cytokine 2000 0.82
7 Sub-visible particle quantitation in protein therapeutics. Pharmeur Bio Sci Notes 2009 0.82
8 Recombinant human albumin as a stabilizer for biological materials and for the preparation of international reference reagents. Biologicals 1998 0.81
9 Identification of transforming growth factor-beta as a contaminant in factor VIII concentrates: a possible link with immunosuppressive effects in hemophiliacs. Blood 1994 0.80
10 Development of a lyophilization formulation that preserves the biological activity of the platelet-inducing cytokine interleukin-11 at low concentrations. J Pharm Pharmacol 2000 0.78
11 Bioassays for the characterisation and control of therapeutic cytokines; determination of potency. Dev Biol Stand 1999 0.77
12 Troglitazone exhibits immunomodulatory activity on the cytokine production of activated human lymphocytes. Horm Metab Res 1999 0.76
13 Protein kinase C-dependent phosphorylation is involved in resistance to tumour necrosis factor-alpha-induced cytotoxicity in a human monocytoid cell line. Biochem J 1993 0.75
14 Detection, measurement and characterization of unwanted antibodies induced by therapeutic biologicals. Dev Biol (Basel) 2005 0.75
15 Biological standardization and control at the World Health Organization: successes, current issues and future challenges. Biologicals 2000 0.75
16 The use of bioassays for the characterisation and control of biological therapeutic products produced by biotechnology. Dev Biol Stand 1997 0.75